Anavex Life Sciences Corp (AVXL)

[tdtcal]

Impediment mine most assuredly. Appreciate your patience.

Now about reasonable. There was a new antibiotic "chemical" that was discovered a few years ago. Never in clinical trials but as it was a potential new "family" of antibiotic was sold for about 1 billion to the pharmaceutical chemist and his group.

As 100 million is usually paid out in tranches, the risk is lowered considerably (and so is the dollar amount) particularly when as each test milestone is met additional investors pile on. Conversely if a milestone isn't met, the payments stop.

Governments are large payers for drugs. They dread diseases that chronically incapacitate people. They will be more agreeable to subsidize a drug that stabilizes a person and keeps them out of nursing homes - which they subsidize as well.

Probably why there have been so many Phase 3 trials at all.